PRESS RELEASE published on 03/26/2026 at 17:45, 6 months 9 days ago Transgene to Deliver an Oral Presentation on its Individualized Neoantigen Therapeutic Vaccine TG4050 at the World Vaccine Congress Transgene to present oral session on TG4050, an Individualized Neoantigen Therapeutic Vaccine, at World Vaccine Congress. Phase 1 findings in head and neck cancer and potential in early-stage treatment to be discussed World Vaccine Congress Vaccine Transgene TG4050 Individualized Neoantigen
BRIEF published on 01/23/2026 at 08:05, 8 months 12 days ago Transgene strengthens its scientific committee with two immunotherapy experts. Immunotherapy Cancer Transgene Antoine Italiano Ignacio Melero
BRIEF published on 01/23/2026 at 08:05, 8 months 12 days ago Transgene renforce son comité scientifique avec deux experts en immunothérapie Immunothérapie Cancer Transgene Antoine Italiano Ignacio Melero
BRIEF published on 01/23/2026 at 08:05, 8 months 12 days ago Transgene Enhances Scientific Advisory Board with New Appointments Scientific Advisory Board Cancer Immunotherapy Transgene Antoine Italiano Ignacio Melero
BRIEF published on 01/23/2026 at 08:05, 8 months 12 days ago Transgene renforce son conseil scientifique consultatif avec de nouvelles nominations Transgene Immunothérapie Du Cancer Ignacio Melero Conseil Scientifique Consultatif Antoine L'Italien
PRESS RELEASE published on 01/23/2026 at 08:00, 8 months 12 days ago Transgene renforce son comité scientifique avec l’arrivée d’Antoine Italiano et Ignacio Melero, deux experts renommés en immunothérapie du cancer Transgene renforce son comité scientifique avec l’arrivée d’Antoine Italiano et Ignacio Melero, experts en immunothérapie du cancer. Ils apporteront une expertise considérable à Transgene pour accélérer le développement de vaccins thérapeutiques anticancéreux Immunothérapie Cancer Transgene Comité Scientifique Experts
PRESS RELEASE published on 01/23/2026 at 08:00, 8 months 12 days ago Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero Transgene strengthens Scientific Advisory Board with renowned cancer immunotherapy experts Prof. Antoine Italiano and Prof. Ignacio Melero. Appointment to accelerate development of myvac® platform and viral vector-based cancer vaccines Scientific Advisory Board Cancer Immunotherapy Transgene Antoine Italiano Ignacio Melero
BRIEF published on 11/27/2025 at 00:20, 10 months 7 days ago Transgene : Reprise de la Cotation sur Euronext Paris Euronext Paris Biotechnologie Augmentation De Capital Cotation Transgene
BRIEF published on 11/27/2025 at 00:20, 10 months 7 days ago Transgene: Resumption of Trading on Euronext Paris Euronext Paris Biotechnology Capital Increase Transgene Quoting
PRESS RELEASE published on 11/27/2025 at 00:15, 10 months 7 days ago Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets Transgene resumes trading of shares on Euronext Paris following capital increase results publication Euronext Paris Shares Trading Capital Increase Transgene
Published on 10/03/2026 at 02:35, 1 day 20 hours ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 2 days 9 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 10 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 10 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/04/2026 at 06:05, 17 hours 6 minutes ago Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 17 hours 56 minutes ago SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 1 day 7 hours ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 23 hours ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 2 days 2 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 17:45, 2 days 5 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 2 days 5 hours ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 2 days 5 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 2 days 5 hours ago Aéroports de Paris SA - Calendrier financier 2027